Latest News

A $400,000 robot which may hold the key to significant improvements in hip and knee replacements is now operational at the Kolling Institute. Known as KOBRA or the Kolling Orthopaedic Biomechanics Robotic Arm, the new technology delivers an advanced testing facility, while greatly increasing research capabilities. It is the largest of its kind in Australia and one of just two SimVitro robots in the.....
Read more

Kolling Institute researchers have helped map out exciting future developments for the rehabilitation of hip and knee replacement patients. A team of researchers from Sydney Musculoskeletal Health – a partnership between the University of Sydney, Sydney Local Health District and Northern Sydney Local Health District - recently attended the International Society for Technology in Arthroplasty’s annu.....
Read more

Improved accessibility to a treatment for kidney disease has been welcomed by Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock. Forxiga (dapagliflozin), an oral medicine which can help slow the progression of proteinuric chronic kidney disease, has now been listed on the Pharmaceutical Benefits Scheme. The listing aims to help those with the condition by.....
Read more

Ambitious leadership, functional wellbeing and a passion for collaboration An international healthcare destination celebrated for its collaborative spirits and dedication to human health and wellbeing. This is Professor Jim Elliott’s vision for how the collaboration between the Kolling Institute, the Faculty of Medicine and Health and the Northern Sydney Local Health District will evolve. Highly re.....
Read more

With a disturbing number of people losing their lives to heart disease each year, researchers have launched the first study of its kind using MRI technology to broaden our understanding of the link between cardiovascular disease and sleep apnoea. The project has been made possible following funding from the Ramsay Research Grant Program, and will involve clinician researchers from Northern Sydney L.....
Read more

A large collection of research projects will get underway at Royal North Shore Hospital following generous funding through the Ramsay Research Grants Program. The scheme has directed more than $10 million to research on the campus over the last 19 years. This year over $700,000 is being invested in a total of 14 innovative studies, all aimed at improving our research impact and the care delivered t.....
Read more

Professor Bruce Robinson has been appointed the NSLHD Chair of Research in an important step towards strengthening research expertise across the district. Professor Robinson, a Kolling Institute researcher, will step into the newly created role this month, bringing a tremendous wealth of research, clinical and policy experience with him. Bruce will be responsible for providing leadership and strate.....
Read more

We may soon have a safer approach to diagnosing and measuring the progression of chronic kidney disease following new research by the team from the Kolling Institute’s Renal Research Laboratory. The condition is a global health issue, which now affects more than 13 per cent of the worldwide population. Chronic kidney disease is a progressive disease that leads to end-stage kidney failure, which is.....
Read more

Professor Jim Elliott has been appointed the Kolling Institute’s new Academic Director. Professor Elliott brings a wealth of experience to the position including a research career spanning more than two decades. He is recognised as a global expert in neck pain and whiplash injuries and leads large scale, multi-centre projects involving collaborators from across the globe. During a period as the Kol.....
Read more

Our researchers are seeking participants for a large-scale clinical trial pioneering the use of stem cells to treat and potentially cure osteoarthritis. The disease is now one of the leading causes of disability in the world, affecting around three million people in Australia alone. Royal North Shore Hospital rheumatologist Professor David Hunter is leading the two-year trial which is recruiting ar.....
Read more